March 15th 2024
Biosimilars market experiences massive growth, but regulatory and adoption challenges remain.
Aligning AB’s Services and Solutions: Willis Chandler
July 8th 2022Willis Chandler, AmerisourceBergen’s recently named President of Biopharma Services, Strategic Global Sourcing and Commercial Solutions, talks about the new investments AB is making to build out its capabilities and its new cell and gene therapy service line.
Selling and Surviving in the New Pharma Landscape
June 3rd 2022Maria Whitman, global head of ZS’s pharmaceutical and biotech practice, talks about the upheaval of the pharma business model and what it means for sales reps; the current skills gap in the marketplace; and how mega-mergers could soon be back on the agenda
A New Approach to the Commercialization Challenges Facing the Oncology Industry
April 8th 2022By 2024 oncology therapeutic sales will hit $250 billion worldwide, and there will be more than 22 million cancer survivors. But commercializing how these critical therapies come to market to help patients hasn’t changed much in the past 20 years. The industry must do more, write Anne Marie Robertson and Ellen Cappellino
Your Engagement Strategy is Only as Good as Your Data
April 8th 2022Leaders from Janssen, Novartis Gene Therapies, Pierre Fabre, and the German cancer app start-up Mika discuss how they are leveraging data in innovative ways to advance their engagement with the scientific community and their overall commercial operations